Precigen (PGEN) Operating Expenses (2012 - 2026)

Precigen (PGEN) has 15 years of Operating Expenses data on file, last reported at $29.2 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $29.2 million, up 22.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.5 million (down 8.67% YoY), and the FY2025 annual result was $120.2 million, down 13.5% from the prior year.
• Operating Expenses climbed to $29.2 million in Q1 2026 per PGEN's latest filing, from $26.2 million in the prior quarter.
• Over five years, Operating Expenses peaked at $61.6 million in Q2 2024 and troughed at $22.2 million in Q3 2024.
• A 5-year average of $29.2 million and a median of $26.2 million in 2025 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses surged 168.96% in 2024, then tumbled 47.01% in 2025.
• A 5-year view of Operating Expenses shows it stood at $23.6 million in 2022, then surged by 50.48% to $35.5 million in 2023, then declined by 16.21% to $29.7 million in 2024, then slipped by 11.7% to $26.2 million in 2025, then grew by 11.49% to $29.2 million in 2026.
• Business Quant data shows PGEN's Operating Expenses at $29.2 million in Q1 2026, $26.2 million in Q4 2025, and $37.4 million in Q3 2025.